BIOTHERA, INC. – Trademark Portfolio
Entity Type: 03
BIOTHERA, INC. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BIOTHERA, WELLMUNE, BETA RIGHT, IMPRIME PGG, and IMMUNE HEALTH BASICS. The owner is based in EAGAN, MN.
3388 MIKE COLLINS DRIVE
EAGAN, MN 551212236
Showing of trademarks Trademarks
Trademark Classifications
BIOTHERA, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does BIOTHERA, INC. have?
BIOTHERA, INC. has 17 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 7 cancelled.
What trademark classes does BIOTHERA, INC. file in?
BIOTHERA, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BIOTHERA, INC.'s most well-known trademarks?
BIOTHERA, INC.'s registered trademark portfolio includes well-known marks such as BIOTHERA, WELLMUNE, BETA RIGHT, IMPRIME PGG, and IMMUNE HEALTH BASICS. These are among 6 currently registered trademarks in the portfolio.
What is BIOTHERA, INC.'s trademark registration success rate?
BIOTHERA, INC. has a 35% trademark registration rate, with 6 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.